Craig A.Tooman

2014

In 2014, Craig A.Tooman earned a total compensation of $909.1K as Chief Financial Officer at Aratana Therapeutics, a 59% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$116,375
Option Awards$336,413
Salary$350,000
Stock Awards$95,900
Other$10,400
Total$909,088

ATooman received $350K in salary, accounting for 39% of the total pay in 2014.

ATooman also received $116.4K in non-equity incentive plan, $336.4K in option awards, $95.9K in stock awards and $10.4K in other compensation.

Rankings

In 2014, Craig A.Tooman's compensation ranked 8,008th out of 13,032 executives tracked by ExecPay. In other words, ATooman earned more than 38.6% of executives.

ClassificationRankingPercentile
All
8,008
out of 13,032
39th
Division
Manufacturing
2,968
out of 4,965
40th
Major group
Chemicals And Allied Products
1,008
out of 1,690
40th
Industry group
Drugs
791
out of 1,369
42nd
Industry
Pharmaceutical Preparations
613
out of 1,042
41st
Source: SEC filing on April 28, 2015.

ATooman's colleagues

We found four more compensation records of executives who worked with Craig A.Tooman at Aratana Therapeutics in 2014.

2014

Steven Peter

Aratana Therapeutics

Chief Executive Officer

2014

Linda Rhodes

Aratana Therapeutics

Chief Scientific Officer

2014

Ernst Heinen

Aratana Therapeutics

Chief Development Officer

2014

Julia Stephanus

Aratana Therapeutics

Chief Commercial Officer

You may also like